Get my own profile
Public access
View all40 articles
0 articles
available
not available
Based on funding mandates
Co-authors
- Changchun XiaoSanofi Institute for Biomedical Research (SIBR), Suzhou, ChinaVerified email at scripps.edu
- Scott RodigProfessor of Pathology, Brigham & Women's HospitalVerified email at bwh.harvard.edu
- Anjana RaoHarvard Medical SchoolVerified email at lji.org
- Sergei KoralovNYU School of MedicineVerified email at nyumc.org
- K Mark AnselProfessor of Microbiology & Immunology, UCSFVerified email at ucsf.edu
- Stefano CasolaFIRC Institute of Molecular Oncology, IFOMVerified email at ifom.eu
- Lars BullingerCharité University Medicine BerlinVerified email at charite.de
- Galler Gunther R.Chief Technology Officer, Genagon TherapeuticsVerified email at genagon.com
- Akihiko YoshimuraKeio University School of MedicineVerified email at a6.keio.jp
- alexander rudenskymskccVerified email at mskcc.org
- Li-Fan LuUniversity of California, San DiegoVerified email at ucsd.edu
- Gabriel LoebUCSFVerified email at ucsf.edu
- Jihye PaikWeill Cornell MedicineVerified email at med.cornell.edu
- John F KearneyProfessor of Microbiology, University of Alabama at BirminghamVerified email at uab.edu
- Ronald A. DePinhoMD AndersonVerified email at mdanderson.org
- Derya UnutmazProfessor at Jackson LaboratoryVerified email at jax.org
- Malcolm WhitmanHarvardVerified email at hms.harvard.edu
- Mark S. SundrudMicrobiology & Immunology, Dartmouth Health, Geisel School of Medicine at DartmouthVerified email at dartmouth.edu
- Markus FeuererLeibniz Institute for Immunotherapy - LITVerified email at ukr.de
- Susana Godinhosenior lecturer, queen mary university londonVerified email at qmul.ac.uk
Follow
Dinis Pedro Calado
Senior Group Leader, The Francis Crick Institute
Verified email at crick.ac.uk - Homepage